Prognostic significance of DNA content and S-phase fraction in epithelial ovarian carcinomas analyzed by image cytometry

Gynecologic Oncology

Volumn 71, Issue 1, 1998, Pages 3-13

  Reles, Angela E ^a,b   Gee, Conway ^c   Schellschmidt, Ilka ^a   Schmider, Annette ^a   Unger, Matthias ^a   Friedmann, Wolfgang ^a   Lichtenegger, Werner ^a   Press, Michael F ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Deoxyribonucleic acid ploidy; Ovarian carcinoma; Prognosis; S phase fraction

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CELL CYCLE S PHASE; CELL SURVIVAL; DNA CONTENT; EPITHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; IMAGE ANALYSIS; IMAGE CYTOMETRY; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVARY CARCINOMA; PLOIDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; TETRAPLOIDY;

EID: 0032191395     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.5156     Document Type: Article

References (36)

1. Swenerton K D, Hislop T G, Spinelli J, LeRiche J C, Yang N, Boyes D A. Ovarian carcinoma: A multivariate analysis of prognostic factors. Obstet Gynecol. 65:1985;264-269.
2. Friedlander M L, Hedley D W, Taylor I W, Russel P, Coates A S, Tattersall M HN. Influence of cellular DNA content on survival in advanced ovarian cancer. Cancer Res. 44:1984;397-400.
3. Kallioniemi O-P, Punnonen R, Mattila J, Lehtinen M, Koivula T. Prognostic significance of DNA index, multiploidy, and S-phase fraction in ovarian cancer. Cancer. 61:1988;334-339.
4. Khoo S K, Battistutta D, Hurst T, Sanderson B, Ward B G, Free K. The prognostic value of clinical, pathologic, and biologic parameters in ovarian cancer. Cancer. 72:1993;531-537.
5. Kaern J, Trope C G, Kristensen G B, Tveit K M, Pettersen E O. Evaluation of desoxyribonucleic acid ploidy and S-phase fraction as prognostic parameters in advanced epithelial ovarian carcinoma: A prospective study. Am J Obstet Gynecol. 180:1994;479-487.
6. Zanetta G, Keeney G L, Cha S S, Farr G H Jr, Katzmann J A, Wieand H S, Edmonson J H, Podratz K C. Flow-cytometric analysis of deoxyribonucleic acid content in advanced ovarian carcinoma: Its importance in long-term survival. Am J Obstet Gynecol. 175:1996;1217-1225.
7. Silvestrini R, Daidone M G, Veneroni S, Benini E, Scarfone G, Zanaboni F, Villa A, Presti M, Danese S, Bolis G. The clinical predictivity of biomarkers of stage III-IV epithelial ovarian cancer in a prospective randomized treatment protocol. Cancer. 82:1998;159-167.
8. Klemi P J, Joensuu H, Mäenpää J, Kilholma P. Influence of cellular DNA content on survival in ovarian carcinoma. Obstet Gynecol. 74:1989;200-204.
9. Barnabei V, Miller D S, Bauer K D, Murad T M, Rademaker A W, Lurain J R. Flow cytometric evaluation of epithelial ovarian cancer. Am J Obstet Gynecol. 162:1990;1584-1592.
10. Pfisterer J, Kommoss F, Sauerbrei W, Renz H, du Bois A, Kiechle-Schwarz M, Pfleiderer A. Cellular DNA content and survival in advanced ovarian carcinoma. Cancer. 74:1994;2509-2515.
11. Wagner T MU, Adler A, Sevelda P, Assmann I, Knepfle C F, Czerwenka K, Heinzl H, Ploem-Zaaijer J J. Prognostic significance of cell DNA content in early-stage ovarian cancer (FIGO stages I and II/A) by means of automatic image cytometry. Int J Cancer. 56:1994;167-172.
12. Schueler J A, Trimbos J B, Burg Mv D, Cornelisse C J, Hermans J, Fleuren G J. DNA index reflects the biological behaviour of ovarian carcinoma stage I-IIa. Gynecol Oncol. 62:1996;59-66.
13. Erba E, Ubezio P, Pepe S, Vaghi M, Marsoni S, Torri W, Mangioni C, Landoni F, D'Incalci M. Flow cytometric analysis of DNA content in human ovarian cancers. Br J Cancer. 60:1989;45-50.
14. Rice L W, Mark S D, Berkowitz R S, Goff B A, Lage J M. Clinicopathologic variables, operative characteristics, and DNA ploidy in predicting outcome in ovarian epithelial carcinoma. Obstet Gynecol. 86:1995;379-385.
15. Resnik E, Trujillo Y P, Taxy J B. Long-term survival and DNA ploidy in advanced epithelial ovarian cancer. J Surg Oncol. 64:1997;299-303.
16. Kaern J, Wetteland J, Tropé C G, Farrants G W, Juhng S-W, Pettersen E O, Reith A, Danielsen H E. Comparison between flow cytometry and image cytometry in ploidy distribution assessments in gynecologic cancer. Cytometry. 13:1992;314-321.
17. Bauer T W, Tubbs R R, Edinger M G, Suit P F, Gephardt G N, Levin H S. Prospective comparison of DNA quantitation by image and flow cytometry. Am J Clin Pathol. 93:1990;322-326.
18. Luzi P, Bruni A, Mangiavacchi P, Cevenini G, Marini D, Tosi P. Ploidy pattern and cell cycle in breast cancer as detected by image analysis and flow cytometry. Cytometry. 18:1994;79-87.
19. Berchuck A, Boente M P, Kerns B J, Kinney R B, Soper J T, Clarke-Pearson D L, Bast R C, Bacus S S. Ploidy analysis of epithelial ovarian cancers using image cytometry. Gynecol Oncol. 44:1992;61-65.
20. Miller B E, Lavia L A, Horbelt D V. The prognostic value of image analysis in ovarian cancer. Cancer. 67:1991;1318-1321.
21. Diebold, J, Suchy, B, Baretton, G, B, Blasenbreu, S, Meier, W, Schmidt, M, Rabes, H, Lohrs, U, 429, 221, 227, 1996.
22. Kosary C L. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers in the female gynecological system: An analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva and vagina. Semin Surg Oncol. 10:1994;31-46.
23. Pettersson F. Annual report on the results of treatment in gynecologic cancer: Statements of the results obtained in patients, 1982 to 1986, inclusive 3- and 5-year survival up to 1990. Int J Gynecol Oncol. 21:1991.
24. Marchevsky A, Tolmachoff T, Lee S. Quality assurance issues in DNA image cytometry. Cytometry. 26:1996;101-107.
25. Freed J A. Possibility of correcting image cytometric nuclear DNA (ploidy) measurements in tissue sections: Insights from computed corpuscle sectioning and the reference curve method. Anal Quant Cytol Histol. 19:1997;376-386.
26. Bacus J W, Grace L J. An optical microscope system of standardized cell measurements and analysis. Appl Opt. 26:1987;3280-3293.
27. Hiddemann W, Schumann J, Andreeff M, Barlogie B, Herman C J, Leif R C, Mayall B H, Murphy R F, Sandberg A A. Convention on nomenclature for DNA cytometry. Cytometry. 5:1984;445-446.
28. Kaplan E L, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
29. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 22:1959;719-748.
30. Cox D R. Regression models and life-tables. J R Stat Soc [B]. 34:1972;187-220.
31. Miller R, Siegmund D. Maximally selected chi square statistics. Biometrics. 38:1982;1011-1016.
32. Halpern J. Maximally selected chi square statistics for small samples. Biometrics. 38:1982;1017-1023.
33. Lausen B, Schumacher M. Maximally selected rank statistics. Biometrics. 48:1992;73-86.
34. Gajewski W H, Fuller A F, Pastel Ley C, Flotte T J, Bell D A. Prognostic significance of DNA content in epithelial ovarian cancer. Gynecol Oncol. 53:1994;5-12.
35. Vergote I B, Kaern J, Abeler V M, Pettersen E O, De Vos L N, Trope C G. Analysis of prognostic factors in stage I epithelial ovarian carcinoma: Importance of degree of differentiation and deoxyribonucleic acid ploidy in predicting relapse. Am J Obstet Gynecol. 169:1993;40-52.
36. Shankey T V, Rabinovitch P S, Bagwell B, Bauer K D, Duque R E, Hedley D W, Mayall B H, Wheeless L. Guidelines for implementation of clinical DNA cytometry. Cytometry. 14:1993;472-477.